TABLE 5.
Compound | Mechanism | References |
---|---|---|
Quercetin | Reduces HBsAg, HBeAg and the secretion of HBV genomic DNA levels. | Cheng et al. (2015) |
Quercetin | Anti‐HBV potential, inhibiting HBsAg and HBeAg synthesis. Molecular docking shows that quercetin forms very stable complexes with HBV polymerase. | Parvez et al. (2019) |
Quercetin | Has higher binding affinity toward Pol/RT than lamivudine. | Parvez et al. (2020) |
Note: HBeAg, HBV secretory protein “e” antigen; HBsAg, Hepatitis B surface antigen; HBV, Hepatitis B virus; IC50, half‐maximal inhibitory concentration; Pol/RT, polymerase/reverse‐transcriptase.